AORTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
ARTIVION, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$22.28+0.50 (+2.30%)
Close on Oct 19, 2026
- Market cap
- $1.08B
- P/E (TTM)
- –
- Dividend yield
- –
ARTIVION, INC. revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medical devices | $370.93M | $358.47M | $345.83M | $328.57M | $312.15M | $297.91M | $290.23M | $284.71M | $277.22M | $270.01M | $261.19M | $250.67M | 78.7% | +18.8% |
| North America | $237.41M | $232.64M | $221.74M | $212.94M | $203.71M | $194.81M | $197.94M | $198.74M | $197.68M | $195.29M | $187.60M | – | 50.4% | +16.5% |
| EMEA | $164.14M | $158.31M | $151.37M | $145.34M | $139.54M | $134.98M | $131.52M | $128.36M | $124.48M | $120.47M | $114.81M | – | 34.8% | +17.6% |
| Preservation services | $100.54M | $100.22M | $95.51M | $94.08M | $92.89M | $92.17M | $98.31M | $100.19M | $99.76M | $98.20M | $92.82M | $89.06M | 21.3% | +8.2% |
| APAC | $45.76M | $44.73M | $44.25M | $41.16M | $39.29M | $37.81M | $37.20M | $36.55M | $34.59M | $33.31M | $33.58M | – | 9.7% | +16.5% |
| LATAM | $24.16M | $23.01M | $23.97M | $23.21M | $22.50M | $22.50M | $21.88M | $21.25M | $20.23M | $19.14M | $18.01M | – | 5.1% | +7.4% |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Products | $370.93M | $358.47M | $345.83M | $328.57M | $312.15M | $297.91M | $290.23M | $284.71M | $277.22M | $270.01M | $261.19M | $250.67M | 78.7% | +18.8% |
| Aortic stent grafts | $173.74M | $167.17M | $159.37M | $146.17M | $135.23M | $127.58M | $123.08M | $120.37M | $117.25M | $113.42M | $107.47M | $103.77M | 36.9% | +28.5% |
| On-X | $111.05M | $106.12M | $101.74M | $96.12M | $90.80M | $85.88M | $83.98M | $81.99M | $79.25M | $76.55M | $74.53M | $71.17M | 23.6% | +22.3% |
| Preservation services | $100.54M | $100.22M | $95.51M | $94.08M | $92.89M | $92.17M | $98.31M | $100.19M | $99.76M | $98.20M | $92.82M | $89.06M | 21.3% | +8.2% |
| Surgical sealants | $77.30M | $77.30M | $76.60M | $76.22M | $75.77M | $75.02M | $73.90M | $72.48M | $70.27M | $68.29M | $68.02M | $65.86M | 16.4% | +2.0% |
| Other | $8.84M | $7.89M | $8.11M | $10.05M | $10.35M | $9.44M | $9.27M | $9.88M | $10.44M | $11.74M | $11.17M | $9.87M | 1.9% | -14.6% |
| International distributors | – | – | – | – | – | – | – | – | – | – | – | $59.09M | – | – |
| Domestic hospitals | – | – | – | – | – | – | – | – | – | – | – | $168.90M | – | – |
| International hospitals | – | – | – | – | – | – | – | – | – | – | – | $107.70M | – | – |
By region
From the segment and revenue-disaggregation notes of Artivion's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.